about
Tigecycline challenge triggers sRNA production in Salmonella enterica serovar TyphimuriumSystematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa.Tigecycline treatment causes a decrease in fibrinogen levelsModulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapyThe Inhibitory Mechanism of Gentamicin on Electrical Field Stimulation Response in Rat Bladder Smooth Muscle.Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in JapanUse of tigecycline in pediatric clinical practice.The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.Development of Tyrocidine A analogues with improved antibacterial activity.Synthesis and antibacterial activity of doxycycline neoglycosides.Daptomycin in bone and joint infections: a review of the literature.Antibiotic resistance patterns in Escherichia coli from gulls in nine European countries.Antimicrobial resistance in Bacteroides spp.: occurrence and dissemination.Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin.Multiresistant bacteria and current therapy - the economical side of the story.Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: a collaboration between dermatologists and infectivologists.Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.Molecular characterization and genetic relatedness of clinically Acinetobacter baumanii isolates conferring increased resistance to the first and second generations of tetracyclines in Iran.Antimicrobial treatment of serious gram-negative infections in newborns.Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited.Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.A daptomycin-xylitol-loaded polymethylmethacrylate bone cement: how much xylitol should be used?TG13 antimicrobial therapy for acute cholangitis and cholecystitis.Comparative in vitro activity of tigecycline and nine other antibiotics against gram-negative bacterial isolates, including ESBL-producing strains.Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens
P2860
Q31089832-FE778EDA-AAE5-4705-9BAD-F8680E1B9F5FQ33776590-38AC2F9C-9824-448E-918F-5F5939FA55F8Q34133346-76127D02-8B34-43CC-9D66-F8E11E337993Q34255044-A6F57540-1D7B-45CE-A829-5F4D03520FE0Q35076823-4FFE6762-AB96-4507-89C1-1CE7FB2660B3Q35142025-7B5969F4-955C-460A-A807-88A957D830CBQ35619094-310E0F15-10AF-4FAC-84AD-1502595CD670Q35960920-A1A227EF-6807-4B74-811E-4023CDAACAB5Q36006946-A9CAA723-3467-4BCE-BE3E-11C120A4C173Q36299968-36ECA327-5EA1-4B8C-A5CD-ADD1168EC59DQ36342430-E049F5E1-3ADA-4324-86B1-D66328AC88FDQ37184911-188CED0D-DADC-4D52-9951-0191B55761F2Q37251382-58213AB8-3C6F-4A7D-84D6-EB8B887A89A3Q37270510-1A03F2E5-D440-468D-BBB3-1660FC72FF92Q37319460-E22AB5F3-387D-419F-AACA-96BA6518C9F9Q37467782-981A14AC-A75A-4BAC-9393-926D1391F37AQ37470575-CD9B15F2-A589-4798-8A33-18A6AD696401Q37608268-E791F767-425C-497C-8127-D704C6878E33Q37731253-3FEE724C-A638-4FDA-8650-98F8607BE675Q37821606-50FBB7F4-3347-4FAF-A677-5C1E104018E6Q37972892-DFE351BE-440F-4023-9661-8871F93DD6C2Q38650049-E29178AF-109E-44B3-845B-978CC6CB121BQ38671665-6595AF42-6FCC-4551-99D7-050FC3DC0E52Q39249188-30131A5C-1379-478D-AC97-E7CA6A0C0448Q40423903-7D434B50-12D4-442B-BEA7-4378890D2C52Q40727658-6C1EBBD9-AB60-469C-8E9E-AEF922245E06Q41904163-8035F7B0-C50F-4FE8-BC8B-6311AA2951A4Q42115764-9FE5F2B1-B874-491C-9D18-83A1AB0F7AD5Q42277917-CC3FE017-E3AA-4404-8933-754E65B9A99DQ45945788-EE5D58EB-6541-4522-B62C-435F6F383CB6Q47677580-E939E27E-E4EF-4852-BE66-3CE00CE470D7Q58703866-3A7880E9-AA64-4DC3-B576-99DF041F6C9A
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Tigecycline: a glycylcycline antimicrobial agent.
@ast
Tigecycline: a glycylcycline antimicrobial agent.
@en
Tigecycline: a glycylcycline antimicrobial agent.
@nl
type
label
Tigecycline: a glycylcycline antimicrobial agent.
@ast
Tigecycline: a glycylcycline antimicrobial agent.
@en
Tigecycline: a glycylcycline antimicrobial agent.
@nl
prefLabel
Tigecycline: a glycylcycline antimicrobial agent.
@ast
Tigecycline: a glycylcycline antimicrobial agent.
@en
Tigecycline: a glycylcycline antimicrobial agent.
@nl
P2093
P1476
Tigecycline: a glycylcycline antimicrobial agent.
@en
P2093
Dhara Mehta
Horatio B Fung
Paul F Riska
Thien-Ly Doan
P304
P356
10.1016/J.CLINTHERA.2006.08.011
P577
2006-08-01T00:00:00Z